Answers are grounded in this paper and cite their sources.
Familial genetic study reveals a novel ACVRL1 variant impairing BMP9 signaling in hereditary hemorrhagic telangiectasia, highlighting mechanisms for early genetic diagnosis.
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular disorder mainly caused by pathogenic variants in ACVRL1 or ENG . We identified a novel heterozygous ACVRL1 p.Cys95Ser variant in a Japanese family with HHT. The variant co-segregated with clinical features and was associated with impaired BMP9-induced signaling, as evidenced by reduced cell-surface expression and increased endoplasmic reticulum retention. These findings expand the HHT mutational spectrum and support early genetic diagnosis.
No takes yet. Share an insight, caveat, or question.
Shimada et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: